In BIN67, the reexpression of BRG1 was comparable and consistent to endogenous protein expression levels in other cancer cell lines, such as HeLa, MCF-7, and 293FT, whereas other SCCOHT cell lines, SCCOHT-1, expressed moderate levels of BRG1 following reexpression (Figure 1—figure supplement 1B, C). This evidence concerns the gene SMARCA4 and cancer.